Related Experiment Video
Updated: Feb 14, 2026

Acute Myocardial Infarction in Rats
Published on: February 16, 2011
Evaluating Rapid Rule-out of Acute Myocardial Infarction Using a High-Sensitivity Cardiac Troponin I Assay at
Jaimi Greenslade1,2, Elizabeth Cho2, Christopher Van Hise2
1Royal Brisbane and Women's Hospital, Herston, Australia; j.greenslade@uq.edu.au.
Insights
A single cardiac troponin I (cTnI) test below 2 ng/L can safely rule out acute myocardial infarction (AMI) in most emergency department patients. This high-sensitivity assay improves diagnostic efficiency and reduces unnecessary assessments.
Area of Science:
- Cardiology
- Emergency Medicine
- Clinical Diagnostics
Background:
- Low cardiac troponin (cTn) concentrations are used for rapid rule-out of acute myocardial infarction (AMI).
- The Beckman Coulter Access high-sensitivity cardiac troponin I (hs-cTnI) assay requires evaluation for a single test threshold for safe AMI rule-out.
Purpose of the Study:
- To identify a single test threshold using the Beckman Coulter Access hs-cTnI assay for the safe rule-out of acute myocardial infarction (AMI).
Main Methods:
- Analysis of stored samples from 1871 patients presenting with acute coronary syndrome symptoms.
- Measurement of hs-cTnI on presentation and calculation of sensitivity and negative predictive value (NPV) for type 1 myocardial infarction (T1MI).
Main Results:
- A hs-cTnI cutoff <2 ng/L demonstrated 99.0% sensitivity and 99.8% NPV for T1MI.
- A cutoff <6 ng/L achieved 99.5% NPV but missed more AMI cases (93.9% sensitivity).
Conclusions:
- A single baseline hs-cTnI <2 ng/L with the Access assay effectively rules out AMI in 99% of patients.
- This threshold can reduce lengthy patient assessments, while a <6 ng/L cutoff is less suitable due to missed AMI cases.
Background:
Low concentrations of cardiac troponin (cTn) have been recommended for rapid rule-out of acute myocardial infarction (AMI). We examined the Beckman Coulter Access high-sensitivity cardiac troponin I (hs-cTnI) assay to identify a single test threshold that can safely rule out AMI.
Methods:
This analysis used stored samples collected in 2 prospective observational studies. In all, 1871 patients presenting to a tertiary emergency department with symptoms of acute coronary syndrome had blood taken for measurement of cTnI on presentation. The endpoint was type 1 myocardial infarction (T1MI). Sensitivity and negative predictive value (NPV) were calculated for hs-cTnI values below the 99th percentile.
Results:
Ninety-eight patients had T1MI (5.2%), and 638 (34.1%) patients had an hs-cTnI <2 ng/L (limit of detection), with sensitivity of 99.0% (95% CI, 94.4%-100%) and NPV of 99.8% (95% CI, 99.1%-100%). No hs-cTnI value above a concentration of 2 ng/L achieved sensitivity of 99%. However, an NPV of 99.5% was achieved at values <6 ng/L. A cutoff <6 ng/L enabled 1475 (78.8%) patients to be ruled out on presentation with sensitivity of 93.9% (95% CI, 87.1%-97.7%).
Conclusions:
A single baseline cTn <2 ng/L measured with the Access hs-cTnI assay performed well for rule-out of AMI. This cutoff concentration identified 99% of patients with AMI and could reduce the number of patients requiring lengthy assessment. A cutoff of <6 ng/L yielded a high NPV but missed more cases of AMI than would be acceptable to clinicians.
More Related Videos
Related Concept Videos
Self-Presentation
Self-Presentation: Self-Monitoring and Self-Handicapping
Strategies of Self-Presentation I: Strategic Self-Presentation
Processes of Self-Presentation
Exceptions to the Octet Rule
Lewis Symbols and the Octet Rule

